Neurogene (NGNE) Receivables (2013 - 2015)

Neurogene's (NGNE) quarterly Receivables came in at $32000.0 in Q4 2015, down 50.77% YoY from $65000.0 in Q4 2014, and up 68.42% on a QoQ basis from $19000.0 in Q3 2015.

Neurogene (NGNE) Receivables (2013 - 2015) Analysis & Trends

Neurogene (NGNE) has 3 years of Receivables data on file, last reported at $32000.0 in Q4 2015.

  • Quarterly Receivables fell 50.77% year-over-year to $32000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $32000.0 (down 50.77% YoY) and the FY2015 annual result came in at $32000.0, down 50.77% from the prior year.
  • Receivables advanced to $32000.0 in Q4 2015, from $19000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $76243.0 in Q3 2014 to a low of $19000.0 in Q3 2015.
  • A 3-year average of $49898.9 and a median of $57000.0 in 2015 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2014 — Receivables surged 132.59% — and 2015, when it plunged 75.08%.
  • Tracing NGNE's Receivables over 3 years: stood at $27946.0 in 2013, then soared by 132.59% to $65000.0 in 2014, then sank by 50.77% to $32000.0 in 2015.
  • The last three Receivables figures came in at $32000.0 (Q4 2015), $19000.0 (Q3 2015), and $72000.0 (Q2 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.93 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.06 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 1.84 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 912.74 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 215.33 Mn
10 Neurogene 815.03 Mn 815.03 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2015 32,000.00
Sep 30, 2015 19,000.00
Jun 30, 2015 72,000.00
Mar 31, 2015 57,000.00
Dec 31, 2014 65,000.00
Sep 30, 2014 76,243.00
Jun 30, 2014 33,375.00
Mar 31, 2014 66,526.00
Dec 31, 2013 27,946.00